India's 2026 IPO Boom and the NRI: How to Apply, What You Actually Get Allotted, and the Tax on Listing Gains

In 2025 India ran 373 IPOs and raised about Rs 1.95 trillion, a twelve-fold jump on a decade earlier, and 2026 has roughly 192 companies in the pipeline targeting another Rs 2.5 lakh crore. If you are an NRI, your WhatsApp groups have spent the last year forwarding screenshots of grey-market premiums and "guaranteed listing pop" tips, and your demat app keeps nudging you to apply. Before you block another Rs 2 lakh of NRE money on the next hot name, here is the part the forwards leave out: by March 2026, about half of 2025's listings were trading below their issue price, the average one from that vintage was down nearly 7%, and the tax on the listing pop you are actually chasing is 20%, not the gentle 12.5% you may be picturing.

The 30-second answer: An NRI applies to Indian IPOs through ASBA, funded from an NRE account (repatriable) or an NRO account (non-repatriable) linked to an NRI demat, choosing the basis at application. Retail applications up to Rs 5 lakh can use UPI; above that, net-banking ASBA is mandatory, and the mainboard retail bucket caps at Rs 2 lakh per application. Allotment in an oversubscribed retail issue is a lottery in lot-sized units, so a big cheque does not buy a bigger chance. If you flip on listing, the gain is short-term, taxed at 20% under Section 111A for sales on or after 23 July 2024, plus surcharge (capped at 15%) and cess, collected as TDS at source. The grey-market premium is unregulated and a poor predictor: in 2025, about half of listings ended up below issue price.

This is a news-analysis piece, not a cheerleading one. It assumes you already have, or know how to open, an NRI demat account and understand the PIS framework; if not, start with the demat setup guide and the buying Indian stocks under PIS guide. What follows is the mechanics of applying as an NRI, the uncomfortable arithmetic of allotment and tax, why the grey market is a trap dressed as a tip, and a sober view on whether chasing listing pops is a strategy or a hobby that happens to lose money.

The boom is real, the returns are not evenly distributed

The headline numbers are genuinely large. Calendar 2025 saw 373 issues raise about Rs 1.95 trillion, with 103 mainboard IPOs mobilising a record Rs 1,75,901 crore and 267 SME IPOs adding another Rs 11,430 crore. Combine 2024 and 2025 and you get roughly Rs 3.8 lakh crore across 701 IPOs, nearly matching the entire five-year haul from 2019 to 2023. The four giants of 2025, Tata Capital, HDB Financial Services, LG Electronics India and ICICI Prudential Asset Management, all listed at a premium, and LG Electronics India was up about 35% from its issue price months later. For 2026, Goldman Sachs and Kotak have floated proceeds of up to USD 25 billion.

Now the distribution, which is where the WhatsApp narrative falls apart. As of March 2026, only about 36% of 2025's 103 mainboard IPOs were trading above their offer price. The average return across that cohort was minus 6.97% and the median was minus 17.71%. On listing day itself, 67% debuted above issue price with an average pop of 9.55%, but that pop is exactly what you cannot reliably capture, and it faded fast: by one count only 41% of the IPOs that gave a listing gain still held it. The worst names were not obscure. Glottis was down about 54%, Gem Aromatics about 49.5%, VMS TMT about 48%, all from a single year's vintage.

The honest framing of the boom is this: it is a fundraising boom for promoters and pre-IPO investors selling into strong demand, not a returns boom for the retail applicant who buys at the top of the hype and holds. A booming primary market and a profitable retail strategy are two different things, and conflating them is the single most expensive mistake an NRI makes here.

How an NRI actually applies, step by step

The application plumbing is the same ASBA system residents use, with one fork that defines everything downstream: repatriable or non-repatriable.

ASBA, Application Supported by Blocked Amount, means your money is not debited when you apply. The amount is blocked in your bank account, you keep earning nothing on it but you keep ownership, and it is only debited if and to the extent you are allotted shares. If you get nothing, the block releases automatically, usually within a few working days of the basis of allotment. For an NRI this matters because it keeps your funds inside your NRE or NRO account, on the right side of the repatriation line, until the moment of allotment.

You apply from an NRE account if you want the repatriable basis: you bring foreign earnings in, the shares are held on a repatriable footing, and the sale proceeds can be sent back abroad freely. You apply from an NRO account for the non-repatriable basis: this uses India-source money or money you do not need to remit out, and proceeds stay in India subject to the USD 1 million per financial year overall NRO repatriation cap. Most NRIs default to NRE for fresh money they may want back home one day, and use NRO only when the issue accepts NRI applications only on a non-repatriable basis, which some do, or when they are deploying existing NRO funds. You choose the basis on the application form; you cannot retrofit it after allotment.

The channels are three. You can submit a physical ASBA form at your bank branch. You can apply online through your bank's net banking ASBA facility, which most NRE/NRO providers now offer. Or you can apply through your broker using UPI, but only if your NRI account is UPI-enabled, which not every bank supports for NRE accounts, and only for applications up to Rs 5 lakh. Above Rs 5 lakh, UPI is not allowed and you must use net-banking ASBA. Separately, the mainboard retail (RII) bucket caps at Rs 2 lakh per application regardless of the UPI ceiling, so a retail NRI application is effectively a Rs 2 lakh-or-less cheque; to bid larger you move into the non-institutional (HNI) category with its own rules and no Rs 2 lakh comfort.

Two practical NRI frictions worth naming. First, your demat must be flagged as an NRI demat under the correct PIS or non-PIS designation, and repatriable and non-repatriable holdings sit in separate demat accounts, so the IPO shares land in whichever account matches the basis you applied on. Second, brokers like Zerodha route NRI IPO applications through ASBA on the linked bank account rather than the broker's own UPI flow in many cases, so the exact button you press depends on your broker. The demat setup guide covers getting these flags right before you ever see a hot IPO, which is the only time to fix them.

The allotment lottery: why your Rs 2 lakh cheque buys one ticket, not ten

Here is the number that deflates most application strategies. When a retail tranche is oversubscribed, allotment is not pro-rata down to fractions. It is a lottery conducted in lot-sized units. Every retail applicant who applied for at least one lot goes into a draw, and either you get the minimum lot or you get nothing. Applying for ten lots in a heavily oversubscribed issue does not give you ten times the chance; if the retail portion is subscribed, say, 20 times, only one in roughly twenty applicants gets the single minimum lot, and the rest get a full refund of the block.

The implication is counterintuitive and worth internalising. In an oversubscribed retail issue, a larger application is mostly wasted capital, because you are competing for the same single-lot lottery as someone who applied for one lot. The way to maximise allotment probability is to apply for one lot per distinct PAN, not many lots on one PAN. Families do this legitimately across different family members' demat accounts, each a separate applicant. What you cannot do is multiply applications on the same PAN; duplicate or technical-rejection applications are simply thrown out.

Put real numbers on it. Suppose a mainboard IPO has a lot of 18 shares at a price band topping out at Rs 555, so one retail lot costs Rs 9,990, and you, an NRI, decide to "go big" and apply for the maximum retail size of about Rs 2,00,000, which is roughly 20 lots. The retail tranche ends up 15 times oversubscribed. Because allotment is a single-lot lottery, your 20-lot application gives you exactly the same probability of getting your one allotted lot as a neighbour who blocked only Rs 9,990. You blocked Rs 2,00,000 of NRE money for a week, earned nothing on it, and if you win you receive one lot worth Rs 9,990; the other Rs 1,90,010 is released back. Had you instead applied for one lot each across two family members' demats, you would have doubled your tickets in the draw for the same Rs 19,980 of blocked capital. The lesson is that in oversubscribed retail issues, more cheque is not more shares; more PANs is.

This is also why the largest, most-hyped IPOs are the worst place to deploy size as a retail NRI: the more oversubscribed, the lower your per-application odds, and the smaller the allotment you can win. Size belongs in the HNI category, which is a different risk calculation entirely and where interest-cost and leverage math, not lottery odds, dominate.

The tax on listing gains is 20%, and it is taken before the money reaches you

Most people chasing IPOs are chasing the listing pop, the gap between issue price and the first-day close, which they intend to sell into within days. That instinct collides with the tax code in a way the grey-market forwards never mention.

A sale within 12 months of acquisition is a short-term capital gain on listed equity. After the Finance (No. 2) Act 2024, for transfers on or after 23 July 2024, the Section 111A rate rose from 15% to 20%, plus surcharge and 4% cess. Crucially, there is no annual exemption on short-term gains; the Rs 1.25 lakh shelter applies only to long-term equity gains. So every rupee of your listing pop, if you flip, is taxed at 20% from the first rupee. Hold beyond 12 months and it converts to a long-term gain at 12.5% above the Rs 1.25 lakh annual threshold, the regime covered in detail in the capital gains guide.

For an NRI there is a second wrinkle residents do not face on the same trade: collection at source. When an NRI sells listed shares, the broker or depository deducts TDS under Section 195 read with 115AD, at 20% on short-term gains and 12.5% on long-term, plus surcharge and cess, so your sale proceeds arrive net of tax. You do not write a cheque to the government later for the basic liability; you reconcile it, and claim any refund or treaty position, when you file your ITR. The cash-flow effect is that the headline pop overstates what lands in your account.

Walk through a realistic flip. You are a UK-resident NRI, you apply on the repatriable basis from your NRE account, and you are allotted one lot of 18 shares at Rs 555, a cost of Rs 9,990. The stock lists with the kind of pop everyone celebrates, and you sell on day one at Rs 720 a share, total Rs 12,960. Ignore the few rupees of brokerage and STT for clarity. Your gain is Rs 12,960 minus Rs 9,990 = Rs 2,970, a tidy 30% in a week on paper.

Now the tax. This is short-term, so 20% applies: Rs 594 of base tax, plus 4% cess of about Rs 24, roughly Rs 618 withheld (surcharge does not bite at this size). Your net gain is about Rs 2,352, not Rs 2,970. On a single lot that is still positive, but notice the shape: the absolute rupees are small because your allotment was small, the tax took a fifth of the gain, and you took 100% of the risk that the stock opened flat or below. As a UK resident you then report this in the UK too and claim a foreign tax credit for the Indian tax to avoid double taxation, more paperwork for Rs 2,352.

Run the counterfactual that the forwards never show. The same lot lists at Rs 480, below the Rs 555 issue price, which is what happened to roughly half of 2025's IPOs. You sell at Rs 480 for Rs 8,640 and book a loss of Rs 1,350. There is no listing pop, no tax to pay, and your only consolation is that a short-term capital loss can be set off against other capital gains and carried forward, the mechanics of which sit in the broader capital gains guide. The point is not that IPOs always lose; it is that the upside on a single retail lot is a few thousand rupees taxed at 20%, while the downside is symmetric and arrives just as often. That is a coin-flip with a house edge against you.

A quick map of the application and tax mechanics

The question	The answer for an NRI
Account to apply from	NRE for repatriable basis, NRO for non-repatriable (USD 1 million/year cap)
Application mechanism	ASBA: amount blocked, not debited, until allotment
UPI allowed?	Yes, up to Rs 5 lakh, only if NRI account is UPI-enabled
Mainboard retail cap	Rs 2 lakh per application; above that is HNI category
Allotment if oversubscribed	Lottery in single lots; bigger cheque does not raise odds
How to raise allotment odds	One lot per distinct PAN across family demats, not many lots on one PAN
Tax if sold within 12 months	Short-term, 20% (Section 111A, from 23 July 2024), no exemption
Tax if held over 12 months	Long-term, 12.5% above Rs 1.25 lakh a year
How tax is collected	TDS at source under Section 195/115AD; proceeds arrive net

The grey market is a trap wearing the costume of a tip

The grey-market premium, the GMP, is the single most misunderstood number in this entire space, and NRIs trading from abroad on forwarded screenshots are especially exposed.

The GMP is an unofficial, unregulated quote for what IPO shares might list at, set by a small set of private dealers who trade applications and "kostak" rates among themselves on trust alone, entirely outside SEBI, NSE and BSE. There is no exchange, no clearing, no settlement guarantee, and no legal recourse if a deal sours. It is not, in any meaningful sense, a price. It is a sentiment reading produced by people who frequently have a position in the very hype they are quoting. When an issue is heavily oversubscribed in the first hours, grey-market participants read that as demand and bid the "premium" up, which then gets screenshotted and forwarded as if it were a forecast.

It is a poor forecast. In 2025, listing-day debuts averaged a 9.55% gain, the kind of number that makes a GMP look prophetic, and then those same names drifted to an average minus 6.97% and a median minus 17.71% within months. A high GMP told you the froth was high on application day; it told you nothing durable about the business. SEBI has been uneasy enough about this that the regulator floated a "when-listed" trading platform to give investors a regulated, transparent venue for pre-listing price discovery and to drain the grey market's relevance. Until that exists and matures, treat any GMP figure as marketing, not data. If your only reason for applying is a screenshot of a premium, you do not have a reason; you have a rationalisation.

Edge cases

RNOR and the year you return. If you are in the Resident but Not Ordinarily Resident window after moving back to India, you are tax-resident in India but your foreign income is sheltered. Your Indian IPO gains, however, are Indian-source and fully taxable in India regardless of RNOR status, and once you become resident you can no longer apply under the NRI reservation; you apply as a resident. Get the account and demat re-designation done before you apply, because applying under the wrong status invites rejection.

US and Canada residents and the broader funds question. This guide is about direct IPO shares, which are fine to hold. The PFIC problem that haunts US and Canada NRIs applies to Indian mutual funds, not to directly-held company shares, so an IPO of an operating company is not a PFIC issue; an IPO-linked mutual fund or an AMC's NFO would need that lens. Keep the distinction clear and read the dedicated guidance before buying any fund wrapper.

The non-repatriable-only issue. Some IPOs accept NRI applications only on a non-repatriable basis. If you applied expecting to remit proceeds abroad and the shares land in your NRO-linked demat, your exit proceeds are stuck behind the USD 1 million annual NRO repatriation limit. Read the NRI section of the offer document before you apply, not after allotment.

Surcharge on a large HNI win. The 20% short-term and 12.5% long-term surcharge on equity gains is capped at 15% even if your total income crosses the higher surcharge bands, the same cap detailed in the capital gains guide. This only matters if you are playing the HNI bucket with large allotments; on a retail single lot it is irrelevant.

The closing read

The honest read is that the 2026 IPO boom is a real fundraising event and a poor retail strategy, and for an NRI the gap between those two things is wider than for a resident because the tax is collected at source and the upside on a single retail lot is small. For most NRIs, the right posture is restraint: apply only to issues you would happily own for years at the offer price, fund them from your NRE account on a repatriable basis so you keep your options open, apply for one lot per PAN across your family rather than wasting capital on a single oversized cheque that buys no extra odds, and ignore the grey-market premium entirely. If you do win a listing pop and flip it, accept that 20% short-term tax and the foreign-tax-credit paperwork eat into a gain that was already only a few thousand rupees, and that the same setup loses money roughly half the time. The exception is the genuine HNI investor with the balance sheet to bid size, take allotment, and hold quality businesses through the post-listing drift; for them, IPOs are one channel into Indian equity among many, covered alongside the PIS route to buying Indian stocks. For everyone else, the boldest, most profitable move in a boom is usually to apply to fewer IPOs, hold the winners, and not confuse a screenshot for a strategy. The wider market context for 2026 sits in the India equity market outlook; the IPO is just the noisiest doorway into it.

Related guides

• NRI investing in IPOs
• Buying Indian stocks under PIS
• Setting up an NRI demat account
• Capital gains tax for NRIs on shares and mutual funds
• India equity market 2026 outlook for NRIs
• All News and commentary
• All Investments guides
• All Taxation guides

This guide is educational and general in nature. It is not investment or tax advice. IPO outcomes are uncertain, past listing performance does not predict future returns, and the tax rules cited changed on 23 July 2024 and may change again. Repatriation limits, your residency status and your country's treatment of Indian gains all affect your position, so confirm the specifics with a qualified chartered accountant and your broker before you apply or sell.